The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-omics analysis from the IMMUcan consortium to identify predictors of chemo-immunotherapy response in early-stage triple-negative breast cancer.
 
Andrea Joaquin Garcia
No Relationships to Disclose
 
Marcela Carausu
No Relationships to Disclose
 
Mattia Rediti
No Relationships to Disclose
 
Marie Morfouace
No Relationships to Disclose
 
David Venet
No Relationships to Disclose
 
Xavier Catteau
No Relationships to Disclose
 
Camille Goudemant
No Relationships to Disclose
 
Elisa Agostinetto
Honoraria - Abscint (Inst); AstraZeneca; Bayer; Lilly
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abscint; AstraZeneca; AstraZeneca; AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; Menarini
 
Daniel Schulz
No Relationships to Disclose
 
Bernd Bodenmiller
No Relationships to Disclose
 
Stephanie Tissot
No Relationships to Disclose
 
Sylvie Rusakiewicz
No Relationships to Disclose
 
Robin Liechti
No Relationships to Disclose
 
Flavia Marzetta
No Relationships to Disclose
 
Nicolas Penel
Honoraria - Astellas Pharma (Inst); MSD (Inst)
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera
Other Relationship - PharmaMar
 
Julio Oliveira
Leadership - Portuguese Oncology Institute of Porto
 
Jean-Charles Goeminne
No Relationships to Disclose
 
Henoch Hong
Employment - Merck KGaA
 
Laurence Buisseret
Honoraria - AstraZeneca (Inst); Novartis (Inst)
Consulting or Advisory Role - Gilead Sciences (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst)
 
Christos Sotiriou
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; CEPHEID; Merck; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - EISAI; Foundation Medicine; Genomic Health; Prime Oncology; Teva
Patents, Royalties, Other Intellectual Property - A companion diagnostic for CDK4/CDK6 inhibitory drugs based on CDK4 Phosphorylation. Which patient to be treated and how. PCT/EP2017/061780; Epigenetic portraits of human Breast Cancer, PCT/EP2012/050836, WO2012/098215
Travel, Accommodations, Expenses - Roche; Roche/Genentech; Roche/Genentech